{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Superficial Surgical Site Infection Rates Between Delayed Primary and Primary Wound Closure for Complicated Appendicitis"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were adults with gangrenous or ruptured appendicitis. They were randomised to either PC or DPC."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were adults with gangrenous or ruptured appendicitis. A multicenter randomised controlled trial was conducted in six hospitals in Thailand."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to either PC or DPC."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to compare SSI rates between delayed primary wound closure (DPC) and primary wound closure (PC)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the rate of superficial SSI within 30 days, defined by the Center for Disease Control criteria."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using permuted blocks, and allocation was concealed in sealed opaque envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to research assistants assessing subjective outcomes."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 607 patients were randomised, with 303 to PC and 304 to DPC."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Modified intention-to-treat analysis included 300 in PC and 298 in DPC."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The SSI rate was 7.3% in PC and 10% in DPC, with a risk difference of \u22122.7% (95% CI \u22127.1% to 1.9%), not statistically significant."
      },
      "Harms": {
        "score": 1,
        "evidence": "No severe adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ClinicalTrials.gov ID NCT01659983."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}